Blackrock Health Sciences Trust

42.32-0.6981-1.62%Vol 20.28K1Y Perf -8.47%
May 18th, 2022 14:38 DELAYED
BID42.15 ASK42.37
Open42.95 Previous Close43.02
Pre-Market- After-Market-
 - -%  - -
Target Price
- 
Analyst Rating
— — 0.00
Potential %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★★★     66.13
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
★★★★★     63.07
Price Range Ratio 52W %
17.44 
Earnings Rating
Market Cap557.63M 
Earnings Date
-
Alpha0.00 Standard Deviation0.05
Beta0.78 

Today's Price Range

42.0643.08

52W Range

40.7549.76

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
2.87%
1 Month
-6.11%
3 Months
1.68%
6 Months
-9.75%
1 Year
-8.47%
3 Years
16.05%
5 Years
24.44%
10 Years
125.02%

TickerPriceChg.Chg.%
BME42.32-0.6981-1.62
AAPL140.48-8.7630-5.87
GOOG2 261.84-72.1901-3.09
MSFT254.82-11.3850-4.28
XOM90.40-1.7100-1.86
WFC42.41-1.3000-2.97
JNJ176.75-2.0700-1.16
FB193.57-9.0500-4.47
GE75.06-1.3400-1.75
JPM120.69-1.4900-1.22
Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume20.28K
Shares Outstanding13.18K
Shares Float13.17M
Trades Count213
Dollar Volume862.57K
Avg. Volume41.85K
Avg. Weekly Volume43.34K
Avg. Monthly Volume43.16K
Avg. Quarterly Volume39.04K

Blackrock Health Sciences Trust (NYSE: BME) stock closed at 43.02 per share at the end of the most recent trading day (a 0.42% change compared to the prior day closing price) with a volume of 32.01K shares and market capitalization of 557.63M. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Asset Management industry, Financial Services sector and employs 0 people. Blackrock Health Sciences Trust CEO is John M. Perlowski.

The one-year performance of Blackrock Health Sciences Trust stock is -8.47%, while year-to-date (YTD) performance is -11.3%. BME stock has a five-year performance of 24.44%. Its 52-week range is between 40.75 and 49.761, which gives BME stock a 52-week price range ratio of 17.44%

Blackrock Health Sciences Trust currently has a PE ratio of 8.90, a price-to-book (PB) ratio of 0.89, a price-to-sale (PS) ratio of 9.46, a price to cashflow ratio of 181.80, a PEG ratio of 2.32, a ROA of 9.83%, a ROC of -% and a ROE of 10.09%. The company’s profit margin is 99.09%, its EBITDA margin is -%, and its revenue ttm is $59.66 Million , which makes it $4.53 revenue per share.

Of the last four earnings reports from Blackrock Health Sciences Trust, there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Blackrock Health Sciences Trust’s next earnings report date is -.

The consensus rating of Wall Street analysts for Blackrock Health Sciences Trust is (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for Blackrock Health Sciences Trust stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Blackrock Health Sciences Trust has a dividend yield of 5.97% with a dividend per share of $2.56 and a payout ratio of 34.00%.

Blackrock Health Sciences Trust has a Sell technical analysis rating based on Technical Indicators (ADX : 10.17, ATR14 : 0.94, CCI20 : -28.28, Chaikin Money Flow : -0.09, MACD : -0.66, Money Flow Index : 49.04, ROC : -0.81, RSI : 46.26, STOCH (14,3) : 58.84, STOCH RSI : 1.00, UO : 46.22, Williams %R : -41.16), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Blackrock Health Sciences Trust in the last 12-months were: Christopher Accettella (Option Excercise at a value of $0), Erin H. Xie (Option Excercise at a value of $0), Jeffrey Gene Lee (Option Excercise at a value of $0), Kyle McClements (Option Excercise at a value of $0)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Summary Rating-
0.00
-
0.00
-
0.00

Blackrock Health Sciences Trust

Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.

CEO: John M. Perlowski

Telephone: +1 800 882-0052

Address: 100 Bellevue Parkway, Wilmington 19809, DE, US

Number of employees: 0

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

54%46%

Bearish Bullish

44%56%

Bearish Bullish

53%47%

News

Stocktwits